{"disease":{"id":"thromboembolic-disorder","name":"Thromboembolic disorder","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"cloricromen","indication_name":"Thromboembolic disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proendotel","generic_name":"CLORICROMEN","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"cloricromen","quality_score":null,"revenue":null,"mechanism":"Cloricromen works by inhibiting platelet aggregation, which is the process by which platelets clump together to form blood clots."},{"drug_id":"warfarin","indication_name":"Thromboembolic disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coumadin","generic_name":"warfarin","company_name":"Generic (originally Wisconsin Alumni Research Foundation)","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7","drug_class":"Vitamin K antagonist (anticoagulant)","quality_score":60,"revenue":null,"mechanism":"Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis."},{"drug_id":"dicoumarol","indication_name":"Thromboembolic disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dicuman","generic_name":"dicoumarol","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"NAD(P)H dehydrogenase [quinone] 1","drug_class":"dicoumarol","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03074539","title":"Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04824118","title":"Clotting Parameters After Medical Abortion","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"NHS Lothian","has_results":false},{"nct_id":"NCT04720092","title":"A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Bayer","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}